title: [Pregabalin (Lyrica) prescription must be cost-effective].
authors.affiliation: Ake.palsson@skane.se
authors.forename: Ake
authors.initials: A
authors.lastname: Pålsson
authors.forename: Lars
authors.initials: L
authors.lastname: Schultz
authors.forename: Nadia
authors.initials: N
authors.lastname: Al-Omar
mesh_terms: D000700:Analgesics / Q000191:economics*; D000927:Anticonvulsants / Q000191:economics*; D003362:Cost-Benefit Analysis; D016527:Drug Costs; D004346:Drug Information Services; D011307:Drug Prescriptions / Q000191:economics; D006801:Humans; D000069583:Pregabalin; D005680:gamma-Aminobutyric Acid / Q000031:analogs & derivatives* / Q000191:economics
chemical_list: D000700:Analgesics; D000927:Anticonvulsants; D000069583:Pregabalin; D005680:gamma-Aminobutyric Acid